Your browser doesn't support javascript.
loading
Iguratimod treatment reduces disease activity in early primary Sjögren's syndrome: An open-label pilot study.
Chen, Hua; Qi, Xuan; Li, Yuan; Wu, Qing; Shi, Qun; Wang, Li; Li, Jing; Zhao, Lidan; Zhang, Li; Zhou, Xinyao; Fei, Yunyun; Liu, Jinjing; Su, Jinmei; Wu, Di; Yang, Yunjiao; Jiang, Hui; Zeng, Xiaofeng; Zhang, Fengchun; Zhao, Yan.
Afiliação
  • Chen H; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Qi X; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, China.
  • Li Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Wu Q; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, China.
  • Shi Q; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Wang L; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, China.
  • Li J; Department of Stomatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Zhao L; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Zhang L; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, China.
  • Zhou X; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Fei Y; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, China.
  • Liu J; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Su J; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, China.
  • Wu D; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Yang Y; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, China.
  • Jiang H; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Zeng X; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, China.
  • Zhang F; Department of Rheumatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Zhao Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Mod Rheumatol ; 31(2): 394-398, 2021 Mar.
Article em En | MEDLINE | ID: mdl-32613869
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Síndrome de Sjogren / Cromonas / Antirreumáticos Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mod Rheumatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Síndrome de Sjogren / Cromonas / Antirreumáticos Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mod Rheumatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China